A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With Hypertension "REFINE HT"


Phase N/A Results N/A

Summary of Purpose

Arterial hypertension has been recognized as a major causal factor for atrial fibrillation (AF), the most common sustained cardiac arrhythmia. In light of its worldwide increasing prevalence and incidence and the accompanied increase in the risk of stroke, thromboembolic events and mortality, AF has emerged as a global healthcare problem. Early diagnosis of AF, prior to the occurrence of complications is a...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 May 2017.

4 Nov 2015 20 Oct 2015 29 Feb 2016 30 May 2016 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Case-Only
  • Perspective: Cross-Sectional
  • Sampling: Probability Sample